Last reviewed · How we verify
treatment of physician's choice — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
treatment of physician's choice (treatment of physician's choice) — Peking Union Medical College Hospital. The drug works by allowing the physician to choose a treatment.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| treatment of physician's choice TARGET | treatment of physician's choice | Peking Union Medical College Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- treatment of physician's choice CI watch — RSS
- treatment of physician's choice CI watch — Atom
- treatment of physician's choice CI watch — JSON
- treatment of physician's choice alone — RSS
Cite this brief
Drug Landscape (2026). treatment of physician's choice — Competitive Intelligence Brief. https://druglandscape.com/ci/treatment-of-physician-s-choice. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab